Antimicrobial Peptides in Nematode Secretions – Unveiling Biotechnological Opportunities for Therapeutics and Beyond

Ela Sutcliffe, Allister Irvine, James Rooney, David Smith, Holly Marie Northcote, Darrin Mckenzie, Somenath Bakshi, Alasdair Nisbet, Daniel Price, Robert Graham, Russell M. Morphew, Louise Atkinson, Angela Mousley, Cinzia Cantacessi

Research output: Contribution to journalReview Articlepeer-review

Abstract

Gastrointestinal (GI) parasitic nematodes threaten food security and affect human health and animal welfare globally. Current anthelmintics for use in humans and livestock are challenged by continuous re-infections and the emergence and spread of multidrug resistance, underscoring an urgent need to identify novel control targets for therapeutic exploitation. Recent evidence has highlighted the occurrence of complex interplay between GI parasitic nematodes of humans and livestock and the resident host gut microbiota. Antimicrobial peptides (AMPs) found within nematode biofluids have emerged as potential effectors of these interactions. This review delves into the occurrence, structure, and function of nematode AMPs, highlighting their potential as targets for drug discovery and development. We argue that an integrated approach combining advanced analytical techniques, scalable production methods, and innovative experimental models is needed to unlock the full potential of nematode AMPs and pave the way for the discovery and development of sustainable parasite control strategies.
Original languageEnglish
Article number108572
JournalAdvances in Biochemical Engineering/Biotechnology
Volume81
Early online date26 Mar 2025
DOIs
Publication statusE-pub ahead of print - 26 Mar 2025

Keywords

  • parasitic nematodes
  • antimicrobial peptides
  • gut microbiota
  • biofluids
  • holobiont
  • peptidomics
  • proteome
  • time-lapse microfluidics
  • gut organoids

Fingerprint

Dive into the research topics of 'Antimicrobial Peptides in Nematode Secretions – Unveiling Biotechnological Opportunities for Therapeutics and Beyond'. Together they form a unique fingerprint.

Cite this